Interruption of Early Cardiovascular Risk Pathways With GLP-1-Based Therapy for Obesity. Everett BM, Ostrominski JW. J Am Coll Cardiol 2026 Jun 9:S0735-1097(26)06566.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Everett BM, Ostrominski JW. Interruption of Early Cardiovascular Risk Pathways With GLP-1-Based Therapy for Obesity. J Am Coll Cardiol 2026 Jun 9:S0735-1097(26)06566.
PMID: 42307498